XRAY Stock Recent News
XRAY LATEST HEADLINES
LOS ANGELES, CA / ACCESSWIRE / July 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / July 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / July 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / July 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.
SAN DIEGO , June 17, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY). Investors, who purchased DENTSPLY SIRONA Inc. (NASDAQ: XRAY) shares in 2021 or earlier and continue to hold any of those NASDAQ: XRAY shares, have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
PHILADELPHIA , June 13, 2024 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Dentsply Sirona Inc. (NASDAQ: XRAY) ("Dentsply") on behalf of the company's long-term investors. Recently an amended securities fraud complaint was filed against Dentsply on behalf of certain investors who purchased shares of the company's stock between June 9, 2021 and November 13, 2022.
CHARLOTTE, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that it is canceling its participation in the Goldman Sachs 45th Annual Global Healthcare Conference due to weather-related flight disruptions. Prior to this announcement, the Company was scheduled to participate on June 13, 2024, at 8:00 am ET.
NEW ORLEANS , June 7, 2024 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.